Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents

European Journal of Medicinal Chemistry

Volumn 51, Issue , 2012, Pages 250-258

  Wang, Ziwen ^a   Wu, Meng ^a   Wang, Yi ^b   Li, Zheng ^a   Wang, Lei ^a   Han, Guifang ^a   Chen, Fazhong ^a   Liu, Yuxiu ^a   Wang, Kailiang ^a   Zhang, Ao ^b   Meng, Linghua ^b   Wang, Qingmin ^a  

^a NANKAI UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

14 Amino derivative; A549; Anti tumor activity; HL60; Phenanthroindolizidine; Phenanthroquinolizidine

Indexed keywords

ANTINEOPLASTIC AGENT; INDOLIZIDINE ALKALOID; PHENANTHRENE DERIVATIVE; QUINOLIZIDINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; BIOASSAY; CANCER CELL CULTURE; CELL STRAIN HL 60; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; REVIEW; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

EID: 84862806711     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.02.048     Document Type: Article

References (33)

1. E. Gellert The indolizidine alkaloids J. Nat. Prod. 45 1982 50 73 (Pubitemid 12102893)
2. J.P. Michael Indolizidine and quinolizidine alkaloids Nat. Prod. Rep. 18 2001 520 542 (Pubitemid 33016992)
3. J.P. Michael Indolizidine and quinolizidine alkaloids Nat. Prod. Rep. 22 2005 603 626 (Pubitemid 41457417)
4. E. Gellert, and R. Rudzats The antileukemia activity of tylocrebrine J. Med. Chem. 7 1964 361 362
5. R.S. Gupta, and L. Siminovitch Mutants of CHO cells resistant to the protein synthesis inhibitors, cryptopleurine and tylocrebrine: genetic and biochemical evidence for common site of action of emetine, cryptopleurine, tylocrebrine, and tubulosine Biochemistry 16 1977 3209 3214 (Pubitemid 8134434)
6. A.G. Damu, P.C. Kuo, L.S. Shi, C.Y. Li, C.S. Kuoh, P.L. Wu, and T.S. Wu Phenanthroindolizidine alkaloids from the stems of Ficus septica J. Nat. Prod. 68 2005 1071 1075 (Pubitemid 41151765)
7. Y. Fu, S.K. Lee, H.Y. Min, T. Lee, J. Lee, M. Cheng, and S. Kim Synthesis and structure-activity studies of antofine analogues as potential anticancer agents Bioorg. Med. Chem. Lett. 17 2007 97 100 (Pubitemid 46001584)
8. L. Wei, A. Brossi, S.L. Morris-Natschke, K.F. Bastow, and K.H. Lee Antitumor agents 248. Chemistry and antitumor activity of tylophorine related alkaloids Studies in Natural Products Chemistry Bioactive Natural Products, Part N vol. 34 2008 pp. 3-34
9. X.M. Yang, Q. Shi, S.C. Yang, C.Y. Chen, S.L. Yu, K.F. Bastow, S.L. Morris-Natschke, P.C. Wu, C.Y. Lai, T.S. Wu, S.L. Pan, C.M. Teng, J.C. Lin, P.C. Yang, and K.H. Lee Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents J. Med. Chem. 54 2011 5097 5107
10. C.W. Yang, W.L. Chen, P.L. Wu, H.Y. Tseng, and S.J. Lee Anti-inflammatory mechanisms of phenanthroindolizidine alkaloids Mol. Pharmacol. 69 2006 749 758
11. X. You, M. Pan, W. Gao, H.S. Shiah, J. Tao, D. Zhang, F. Koumpouras, S. Wang, H. Zhao, J.A. Madri, D. Baker, Y.C. Cheng, and Z. Yin Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response Arthritis Rheum. 54 2006 877 886
12. J.Y. Choi, W. Gao, J. Odegard, H.S. Shiah, M. Kashgarian, J.M. McNiff, D.C. Baker, Y.C. Cheng, and J. Craft Abrogation of skin disease in LUPUS-prone MRL/FASIpr mice by means of a novel tylophorine analog Arthritis Rheum. 54 2006 3277 3283 (Pubitemid 44622098)
13. S.R. Chemler Phenanthroindolizidines and phenanthroquinolizidines: promising alkaloids for anti-cancer therapy Curr. Bioact. Compd. 5 2009 2 19
14. Z.G. Li, Z. Jin, and R.Q. Huang Synthesis and biological activity of phenanthroindolizidine and phenanthroquinolizidine alkaloids Synthesis 16 2001 2365 2378 (Pubitemid 33131974)
15. R.N.L.C. Chopra, N.N. De, and M. Chakerburty The pharmacological action of tylophorine: the alkaloid occurring in Tylophora asthmaticus Indian J. Med. Res. 23 1935 263 269
16. M. Suffness, and J. Douros Anticancer Agents Based on Natural Product Models 1980 Academic Press pp. 465-487
17. The 60-cell line NCI test data, along with in vivo data, can be accessed from the NSC numbers at the following website: http://dtp.nci.nih.gov/ dtpstandard/dwindex/index.jsp.
18. G.R. Donaldson, M.R. Atkinson, and A.W. Murray Inhibition of protein synthesis in ehrlich ascites-tumor cells by the phenanthrene alkaloids Biochem. Biophys. Res. Commun. 31 1968 104 109
19. M.T. Huang, and A.P. Grollman Mode of action of tylocrebrine: effects on protein and nucleic acid synthesis Mol. Pharmacol. 8 1972 538 550
20. W. Gao, W. Lam, S. Zhong, C. Kaczmarek, D.C. Baker, and Y.C. Cheng Novel mode of action of tylophorine analogs as antitumor compounds Cancer Res. 64 2004 678 688 (Pubitemid 38120910)
21. H.S. Shiah, W. Gao, D.C. Baker, and Y.C. Cheng Inhibition of cell growth and nuclear factor-κB activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503 Mol. Cancer Ther. 5 2006 2484 2493 (Pubitemid 44650912)
22. H.Y. Min, H.J. Chung, E.H. Kim, S. Kim, E.J. Park, and S.K. Lee Inhibition of cell growth and potentiation of tumor necrosis factor-α TNF-α-induced apoptosis by a phenanthroindolizidine alkaloid antofine in human colon cancer cells Biochem. Pharmacol. 80 2010 1356 1364
23. Z. Xi, R.Y. Zhang, Z.H. Yu, D. Ouyang, and R.Q. Huang Selective interaction between tylophorine B and bulged DNA Bioorg. Med. Chem. Lett. 15 2005 2673 2677 (Pubitemid 40615010)
24. K.L. Wang, M.Y. Lü, Q.M. Wang, and R.Q. Huang Iron(III) chloride-based mild synthesis of phenanthrene and its application to total synthesis of phenanthroindolizidine alkaloids Tetrahedron 64 2008 7504 7510
25. K.L. Wang, Y.N. Hu, Z. Li, M. Wu, Z.H. Liu, B. Su, A. Yu, Y. Liu, and Q.M. Wang A simple and efficient oxidative coupling of aromatic nuclei mediated by manganese dioxide Synthesis 7 2010 1083 1090
26. W.L. Gao, S. Busson, S.P. Grill, E.A. Gullen, Y.C. Hu, X. Huang, S.B. Zhong, C. Kaczmarek, J. Gutierrez, S. Francis, D.C. Baker, S. Yu, and Y.C. Cheng Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents Bioorg. Med. Chem. Lett. 17 2007 4338 4342 (Pubitemid 47021384)
27. T.F. Buckley, and H. Rapoport Amino acids as chiral educts for asymmetric products. Chirally specific syntheses of tylophorine and cryptopleurine J. Org. Chem. 48 1983 4222 4232 (Pubitemid 14185236)
28. Z.W. Wang, Z. Li, K.L. Wang, and Q.M. Wang Efficient and chirally specific synthesis of phenanthro-indolizidine alkaloids by Parham-type cycloacylation Eur. J. Org. Chem. 2 2010 292 299
29. M. Wu, L. Li, B. Su, Z.H. Liu, and Q.M. Wang First total synthesis of (-)-and (+)-6-O-desmethylantofine Org. Biomol. Chem. 9 2011 141 145
30. Z.W. Wang, L. Wang, and Q.M. Wang The first and efficient synthesis of 14-aminophenanthro-indolizidine alkaloids Synthesis 6 2011 979 983
31. Z.W. Wang, and Q.M. Wang Highly efficient synthesis of phenanthroquinolizidine alkaloids via Parham-type cycliacylation Tetrahedron Lett. 10 2010 1377 1379
32. H. Shirai, and N. Oda Studies on phenanthrene derivatives. IV. Syntheses of 2,3:5,6-bismethylenedioxy and 2,3:6,7-bismethylenedioxyphenanthrene and ultraviolet absorption spectra of certain methylenedioxyphenanthrenes Chem. Pharm. Bull. 1 1962 31 37
33. J.J. Lu, L.H. Meng, Y.J. Cai, Q. Chen, L.J. Tong, L.P. Lin, and J. Ding Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species Cancer Biol. Ther. 7 2008 1017 1023